- CSR Summary Not Yet Available
- NCT00915655
- Primary Citation Not Available
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameDarunavirProduct NamePREZISTA®Therapeutic AreaImmune System DiseasesEnrollment12% Female66.7%% WhiteN/A
Product ClassAntiviral AgentSponsor Protocol NumberTMC114-TiDP29-C230Data PartnerJohnson & JohnsonCondition StudiedHIV InfectionsMean/Median Age (Years)14.7
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available